We have observed
14 EP applications
Karen Dorothee Larbig
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
USE OF ORGANIC COMPOUND FOR THE TREATMENT OF NOONAN SYNDROME
PHARMACEUTICAL COMPOSITIONS COMPRISING AN AROMATASE INHIBITOR
USE OF AN AROMATASE INHIBITOR FOR THE TREATMENT OF HYPOGONADISM AND RELATED DISEASES
NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING
PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NEUTRAL ENDOPEPTIDASE (NEP) INHIBITOR
PROCESS AND INTERMEDIATES FOR THE PREPARATION OF NEP INHIBITORS
SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING HEART FAILURE
SACUBITRIL AND VALSARTAN FOR TREATING METABOLIC DISEASE
SACUBITRIL CALCIUM SALTS
NEW PROCESS AND INTERMEDIATES